The 14 references in paper Yu. FEDOTKINA A., E. PANCHENKO P., Ю. ФЕДОТКИНА А., Е. ПАНЧЕНКО П. (2017) “ТРОМБОЗЫ В ОНКОЛОГИИ. ЧАСТЬ 2 // THROMBOSIS IN CANCER. PART 2” / spz:neicon:aterotromboz:y:2017:i:2:p:3-12

1
Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. Clin. Oncol,2009, 27:4839-4847.
(check this in PDF content)
2
Андрияшкин В.В., Кириенко А.И., Явелов И.С. и соавт. Российские клинические рекомендации по профилактике и лечению венозных тромбоэмболических осложнений у онкологических больных. 2014: 10-11.
(check this in PDF content)
3
Kucher N, Koo S, Quiroz R et al. Electronic Alerts to Prevent Venou Thromboembolism among Hospitalized Patients. N Engl J Med, 2005, 352: 969-977.
(check this in PDF content)
4
Khorana AA, Kuderer NM, Culakova E. Development and Validation of a predictive model for chemotherapy-associated thrombosis. Blood, 2008, 111 (10): 4902-4907.
(check this in PDF content)
5
Khorana AA. Riskassessment andprofilaxis for VTE in cancer patients. Natl Compr Canc Netw, 2011, 9: 789797.
(check this in PDF content)
6
Khorana AA., Carrier M., Garcia DA., et al. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Tromb Thrombolysis, 2016, 41: 91-91.
(check this in PDF content)
7
Henry G. Watson, David M. Keeling et. al. Guideline on aspects of cancer-related venous thrombosis. British Journal of Haematology, 2015, 170: 640-648.
(check this in PDF content)
8
Zamorano JL, Lancellotti P, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicitr developed under the auspices of the ESC Committee for Practice Guidelines. EHJ. doi:10.1093/eurheat/ehw 211.
(check this in PDF content)
9
Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, Hantel S, Feuring M, Kreuzer J. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer. Thromb Haemost,2015, 114: 150–157.
(check this in PDF content)
10
Vedovati MC, et al. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis. Chest,2015, 147: 475–483.
(check this in PDF content)
11
Gerotziafas GT, Mahe I, Elalamy I. New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients. Ther Clin Risk Manag,2014, 10: 423–436.
(check this in PDF content)
12
Kearon C et al. Antithrombotic Therapy for VTE Disease. Chest Guidelines and Expert Panel Report. Chest,2016, 149(2): 315-352.
(check this in PDF content)
13
Alok A. Khorana, Marc Carrier, et. Al. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis, 2016, 41: 81-91.
(check this in PDF content)
14
Lyman GH, Khorana AA, Kuderer NM et al. Venous thromboembolism prophilaxis and treatment in patients with cancer; American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol, 2013, 31(17): 2189-2204.
(check this in PDF content)